Mass. insurer end coverage of compounded drugs
BOSTON (AP) - The second largest health insurer in Massachusetts has announced that it will no longer cover specialty medications known as compounded drugs, months after a deadly nationwide meningitis outbreak was traced to a Massachusetts compounding pharmacy.
The chief medical officer at Harvard Pilgrim Health Care says the policy stems from a safety review after the meningitis outbreak traced to tainted steroids produced at New England Compounding Center in Framingham that killed 58.
Dr. Michael Sherman tells The Boston Globe (http://b.globe.com/14yr7op ) that most of the insurance claims it received from patients for compounded drugs were for medications that should not be covered by a health insurer.
The coverage ends Aug. 7, but Harvard Pilgrim will consider appeals on a case by case basis.
The decision drew fire from pharmacists and patient advocates.
TALK TO US
If you'd like to leave a comment (or a tip or a question) about this story with the editors, please email us. We also welcome letters to the editor for publication; you can do that by filling out our letters form and submitting it to the newsroom.